Speaker Company: Amgen

Biosimilar Market Growth: Managing Cost Trends Rewarding Biopharmaceutical Innovation

Healthcare Integration Enables an Innovative Migraine VBC: Tying Net Price to Value

Collaborating to Promote Specialty Drug Access and Improved Health Outcomes for Patients

Specialty Cost Trends and Biosimilars: Responding to Payer Cost Concerns and Rewarding Biopharmaceutical Innovation

Opportunities for Value Based Arrangements in Oncology and Rare Diseases